Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1 1

Status

Terminated 5Completed 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 2Tumor-Agnostic 1Breast 1

Conditions

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Breast Cancer Metastatic 1Adenocarcinoma Gastric 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
tusamitamab ravtansine × 1 year × Clear all
NCT04154956 2026-05-18

CARMEN-LC03

Sanofi

Phase 3 Terminated
389 enrolled 16 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT04524689 2025-10-29

CARMEN-LC05

Sanofi

Phase 2 Terminated
57 enrolled 26 charts
Thoracic

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

NCT04659603 2025-10-01

CARMEN-BT01

Sanofi

Phase 2 Terminated
50 enrolled 20 charts
BreastGastrointestinal

Breast Cancer Metastatic

NCT05245071 2025-08-29

CARMEN-LC06

Sanofi

Phase 2 Terminated
22 enrolled 11 charts
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated
35 enrolled 14 charts
Gastrointestinal

Adenocarcinoma Gastric

NCT03324113 2025-08-05

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

Sanofi

Phase 1 Completed
34 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡